Hyperimmune Globulins Industry Research Report 2024
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. This is in contrast to vaccines that provide 'active' immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant 'passive' short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
According to APO Research, the global Hyperimmune Globulins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%.
Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent.
In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hyperimmune Globulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperimmune Globulins.
The report will help the Hyperimmune Globulins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Hyperimmune Globulins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hyperimmune Globulins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyperimmune Globulins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hyperimmune Globulins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyperimmune Globulins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hyperimmune Globulins manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hyperimmune Globulins by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hyperimmune Globulins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
According to APO Research, the global Hyperimmune Globulins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%.
Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent.
In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hyperimmune Globulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperimmune Globulins.
The report will help the Hyperimmune Globulins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Hyperimmune Globulins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hyperimmune Globulins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- CSL Behring
- Grifols
- Biotest
- Kedrion
- CBPO
- Emergent (Cangene)
- Kamada
- CNBG
- Hualan Bio
- Shanghai RAAS
- Sichuan Yuanda Shuyang
- ADMA Biologics
- Hepatitis B Immunoglobulins
- Rabies Immunoglobulins
- Tetanus Immunoglobulins
- Rho(D) Immunoglobulins
- Other
- Government Institutions
- Private Sector
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyperimmune Globulins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hyperimmune Globulins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyperimmune Globulins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hyperimmune Globulins manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hyperimmune Globulins by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hyperimmune Globulins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Hyperimmune Globulins Market Size (2019-2030) & (US$ Million)
2.2.2 Global Hyperimmune Globulins Sales (2019-2030)
2.2.3 Global Hyperimmune Globulins Market Average Price (2019-2030)
2.3 Hyperimmune Globulins by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Hepatitis B Immunoglobulins
2.3.3 Rabies Immunoglobulins
2.3.4 Tetanus Immunoglobulins
2.3.5 Rho(D) Immunoglobulins
2.3.6 Other
2.4 Hyperimmune Globulins by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Government Institutions
2.4.3 Private Sector
2.4.4 Other
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Hyperimmune Globulins Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Hyperimmune Globulins Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Hyperimmune Globulins Revenue of Manufacturers (2019-2024)
3.4 Global Hyperimmune Globulins Average Price by Manufacturers (2019-2024)
3.5 Global Hyperimmune Globulins Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Hyperimmune Globulins, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Hyperimmune Globulins, Product Type & Application
3.8 Global Manufacturers of Hyperimmune Globulins, Date of Enter into This Industry
3.9 Global Hyperimmune Globulins Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 CSL Behring
4.1.1 CSL Behring Company Information
4.1.2 CSL Behring Business Overview
4.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.1.4 CSL Behring Hyperimmune Globulins Product Portfolio
4.1.5 CSL Behring Recent Developments
4.2 Grifols
4.2.1 Grifols Company Information
4.2.2 Grifols Business Overview
4.2.3 Grifols Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Grifols Hyperimmune Globulins Product Portfolio
4.2.5 Grifols Recent Developments
4.3 Biotest
4.3.1 Biotest Company Information
4.3.2 Biotest Business Overview
4.3.3 Biotest Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Biotest Hyperimmune Globulins Product Portfolio
4.3.5 Biotest Recent Developments
4.4 Kedrion
4.4.1 Kedrion Company Information
4.4.2 Kedrion Business Overview
4.4.3 Kedrion Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Kedrion Hyperimmune Globulins Product Portfolio
4.4.5 Kedrion Recent Developments
4.5 CBPO
4.5.1 CBPO Company Information
4.5.2 CBPO Business Overview
4.5.3 CBPO Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.5.4 CBPO Hyperimmune Globulins Product Portfolio
4.5.5 CBPO Recent Developments
4.6 Emergent (Cangene)
4.6.1 Emergent (Cangene) Company Information
4.6.2 Emergent (Cangene) Business Overview
4.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Emergent (Cangene) Hyperimmune Globulins Product Portfolio
4.6.5 Emergent (Cangene) Recent Developments
4.7 Kamada
4.7.1 Kamada Company Information
4.7.2 Kamada Business Overview
4.7.3 Kamada Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Kamada Hyperimmune Globulins Product Portfolio
4.7.5 Kamada Recent Developments
4.8 CNBG
4.8.1 CNBG Company Information
4.8.2 CNBG Business Overview
4.8.3 CNBG Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.8.4 CNBG Hyperimmune Globulins Product Portfolio
4.8.5 CNBG Recent Developments
4.9 Hualan Bio
4.9.1 Hualan Bio Company Information
4.9.2 Hualan Bio Business Overview
4.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Hualan Bio Hyperimmune Globulins Product Portfolio
4.9.5 Hualan Bio Recent Developments
4.10 Shanghai RAAS
4.10.1 Shanghai RAAS Company Information
4.10.2 Shanghai RAAS Business Overview
4.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Shanghai RAAS Hyperimmune Globulins Product Portfolio
4.10.5 Shanghai RAAS Recent Developments
4.11 Sichuan Yuanda Shuyang
4.11.1 Sichuan Yuanda Shuyang Company Information
4.11.2 Sichuan Yuanda Shuyang Business Overview
4.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Portfolio
4.11.5 Sichuan Yuanda Shuyang Recent Developments
4.12 ADMA Biologics
4.12.1 ADMA Biologics Company Information
4.12.2 ADMA Biologics Business Overview
4.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.12.4 ADMA Biologics Hyperimmune Globulins Product Portfolio
4.12.5 ADMA Biologics Recent Developments
5 GLOBAL HYPERIMMUNE GLOBULINS MARKET SCENARIO BY REGION
5.1 Global Hyperimmune Globulins Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Hyperimmune Globulins Sales by Region: 2019-2030
5.2.1 Global Hyperimmune Globulins Sales by Region: 2019-2024
5.2.2 Global Hyperimmune Globulins Sales by Region: 2025-2030
5.3 Global Hyperimmune Globulins Revenue by Region: 2019-2030
5.3.1 Global Hyperimmune Globulins Revenue by Region: 2019-2024
5.3.2 Global Hyperimmune Globulins Revenue by Region: 2025-2030
5.4 North America Hyperimmune Globulins Market Facts & Figures by Country
5.4.1 North America Hyperimmune Globulins Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Hyperimmune Globulins Sales by Country (2019-2030)
5.4.3 North America Hyperimmune Globulins Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Hyperimmune Globulins Market Facts & Figures by Country
5.5.1 Europe Hyperimmune Globulins Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Hyperimmune Globulins Sales by Country (2019-2030)
5.5.3 Europe Hyperimmune Globulins Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Hyperimmune Globulins Market Facts & Figures by Country
5.6.1 Asia Pacific Hyperimmune Globulins Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Hyperimmune Globulins Sales by Country (2019-2030)
5.6.3 Asia Pacific Hyperimmune Globulins Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Hyperimmune Globulins Market Facts & Figures by Country
5.7.1 Latin America Hyperimmune Globulins Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Hyperimmune Globulins Sales by Country (2019-2030)
5.7.3 Latin America Hyperimmune Globulins Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Hyperimmune Globulins Market Facts & Figures by Country
5.8.1 Middle East and Africa Hyperimmune Globulins Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Hyperimmune Globulins Sales by Country (2019-2030)
5.8.3 Middle East and Africa Hyperimmune Globulins Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Hyperimmune Globulins Sales by Type (2019-2030)
6.1.1 Global Hyperimmune Globulins Sales by Type (2019-2030) & (K Units)
6.1.2 Global Hyperimmune Globulins Sales Market Share by Type (2019-2030)
6.2 Global Hyperimmune Globulins Revenue by Type (2019-2030)
6.2.1 Global Hyperimmune Globulins Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Hyperimmune Globulins Revenue Market Share by Type (2019-2030)
6.3 Global Hyperimmune Globulins Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Hyperimmune Globulins Sales by Application (2019-2030)
7.1.1 Global Hyperimmune Globulins Sales by Application (2019-2030) & (K Units)
7.1.2 Global Hyperimmune Globulins Sales Market Share by Application (2019-2030)
7.2 Global Hyperimmune Globulins Revenue by Application (2019-2030)
7.2.1 Global Hyperimmune Globulins Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Hyperimmune Globulins Revenue Market Share by Application (2019-2030)
7.3 Global Hyperimmune Globulins Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Hyperimmune Globulins Value Chain Analysis
8.1.1 Hyperimmune Globulins Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Hyperimmune Globulins Production Mode & Process
8.2 Hyperimmune Globulins Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Hyperimmune Globulins Distributors
8.2.3 Hyperimmune Globulins Customers
9 GLOBAL HYPERIMMUNE GLOBULINS ANALYZING MARKET DYNAMICS
9.1 Hyperimmune Globulins Industry Trends
9.2 Hyperimmune Globulins Industry Drivers
9.3 Hyperimmune Globulins Industry Opportunities and Challenges
9.4 Hyperimmune Globulins Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Hyperimmune Globulins Market Size (2019-2030) & (US$ Million)
2.2.2 Global Hyperimmune Globulins Sales (2019-2030)
2.2.3 Global Hyperimmune Globulins Market Average Price (2019-2030)
2.3 Hyperimmune Globulins by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Hepatitis B Immunoglobulins
2.3.3 Rabies Immunoglobulins
2.3.4 Tetanus Immunoglobulins
2.3.5 Rho(D) Immunoglobulins
2.3.6 Other
2.4 Hyperimmune Globulins by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Government Institutions
2.4.3 Private Sector
2.4.4 Other
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Hyperimmune Globulins Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Hyperimmune Globulins Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Hyperimmune Globulins Revenue of Manufacturers (2019-2024)
3.4 Global Hyperimmune Globulins Average Price by Manufacturers (2019-2024)
3.5 Global Hyperimmune Globulins Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Hyperimmune Globulins, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Hyperimmune Globulins, Product Type & Application
3.8 Global Manufacturers of Hyperimmune Globulins, Date of Enter into This Industry
3.9 Global Hyperimmune Globulins Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 CSL Behring
4.1.1 CSL Behring Company Information
4.1.2 CSL Behring Business Overview
4.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.1.4 CSL Behring Hyperimmune Globulins Product Portfolio
4.1.5 CSL Behring Recent Developments
4.2 Grifols
4.2.1 Grifols Company Information
4.2.2 Grifols Business Overview
4.2.3 Grifols Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Grifols Hyperimmune Globulins Product Portfolio
4.2.5 Grifols Recent Developments
4.3 Biotest
4.3.1 Biotest Company Information
4.3.2 Biotest Business Overview
4.3.3 Biotest Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Biotest Hyperimmune Globulins Product Portfolio
4.3.5 Biotest Recent Developments
4.4 Kedrion
4.4.1 Kedrion Company Information
4.4.2 Kedrion Business Overview
4.4.3 Kedrion Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Kedrion Hyperimmune Globulins Product Portfolio
4.4.5 Kedrion Recent Developments
4.5 CBPO
4.5.1 CBPO Company Information
4.5.2 CBPO Business Overview
4.5.3 CBPO Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.5.4 CBPO Hyperimmune Globulins Product Portfolio
4.5.5 CBPO Recent Developments
4.6 Emergent (Cangene)
4.6.1 Emergent (Cangene) Company Information
4.6.2 Emergent (Cangene) Business Overview
4.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Emergent (Cangene) Hyperimmune Globulins Product Portfolio
4.6.5 Emergent (Cangene) Recent Developments
4.7 Kamada
4.7.1 Kamada Company Information
4.7.2 Kamada Business Overview
4.7.3 Kamada Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Kamada Hyperimmune Globulins Product Portfolio
4.7.5 Kamada Recent Developments
4.8 CNBG
4.8.1 CNBG Company Information
4.8.2 CNBG Business Overview
4.8.3 CNBG Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.8.4 CNBG Hyperimmune Globulins Product Portfolio
4.8.5 CNBG Recent Developments
4.9 Hualan Bio
4.9.1 Hualan Bio Company Information
4.9.2 Hualan Bio Business Overview
4.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Hualan Bio Hyperimmune Globulins Product Portfolio
4.9.5 Hualan Bio Recent Developments
4.10 Shanghai RAAS
4.10.1 Shanghai RAAS Company Information
4.10.2 Shanghai RAAS Business Overview
4.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Shanghai RAAS Hyperimmune Globulins Product Portfolio
4.10.5 Shanghai RAAS Recent Developments
4.11 Sichuan Yuanda Shuyang
4.11.1 Sichuan Yuanda Shuyang Company Information
4.11.2 Sichuan Yuanda Shuyang Business Overview
4.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Portfolio
4.11.5 Sichuan Yuanda Shuyang Recent Developments
4.12 ADMA Biologics
4.12.1 ADMA Biologics Company Information
4.12.2 ADMA Biologics Business Overview
4.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)
4.12.4 ADMA Biologics Hyperimmune Globulins Product Portfolio
4.12.5 ADMA Biologics Recent Developments
5 GLOBAL HYPERIMMUNE GLOBULINS MARKET SCENARIO BY REGION
5.1 Global Hyperimmune Globulins Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Hyperimmune Globulins Sales by Region: 2019-2030
5.2.1 Global Hyperimmune Globulins Sales by Region: 2019-2024
5.2.2 Global Hyperimmune Globulins Sales by Region: 2025-2030
5.3 Global Hyperimmune Globulins Revenue by Region: 2019-2030
5.3.1 Global Hyperimmune Globulins Revenue by Region: 2019-2024
5.3.2 Global Hyperimmune Globulins Revenue by Region: 2025-2030
5.4 North America Hyperimmune Globulins Market Facts & Figures by Country
5.4.1 North America Hyperimmune Globulins Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Hyperimmune Globulins Sales by Country (2019-2030)
5.4.3 North America Hyperimmune Globulins Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Hyperimmune Globulins Market Facts & Figures by Country
5.5.1 Europe Hyperimmune Globulins Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Hyperimmune Globulins Sales by Country (2019-2030)
5.5.3 Europe Hyperimmune Globulins Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Hyperimmune Globulins Market Facts & Figures by Country
5.6.1 Asia Pacific Hyperimmune Globulins Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Hyperimmune Globulins Sales by Country (2019-2030)
5.6.3 Asia Pacific Hyperimmune Globulins Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Hyperimmune Globulins Market Facts & Figures by Country
5.7.1 Latin America Hyperimmune Globulins Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Hyperimmune Globulins Sales by Country (2019-2030)
5.7.3 Latin America Hyperimmune Globulins Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Hyperimmune Globulins Market Facts & Figures by Country
5.8.1 Middle East and Africa Hyperimmune Globulins Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Hyperimmune Globulins Sales by Country (2019-2030)
5.8.3 Middle East and Africa Hyperimmune Globulins Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Hyperimmune Globulins Sales by Type (2019-2030)
6.1.1 Global Hyperimmune Globulins Sales by Type (2019-2030) & (K Units)
6.1.2 Global Hyperimmune Globulins Sales Market Share by Type (2019-2030)
6.2 Global Hyperimmune Globulins Revenue by Type (2019-2030)
6.2.1 Global Hyperimmune Globulins Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Hyperimmune Globulins Revenue Market Share by Type (2019-2030)
6.3 Global Hyperimmune Globulins Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Hyperimmune Globulins Sales by Application (2019-2030)
7.1.1 Global Hyperimmune Globulins Sales by Application (2019-2030) & (K Units)
7.1.2 Global Hyperimmune Globulins Sales Market Share by Application (2019-2030)
7.2 Global Hyperimmune Globulins Revenue by Application (2019-2030)
7.2.1 Global Hyperimmune Globulins Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Hyperimmune Globulins Revenue Market Share by Application (2019-2030)
7.3 Global Hyperimmune Globulins Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Hyperimmune Globulins Value Chain Analysis
8.1.1 Hyperimmune Globulins Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Hyperimmune Globulins Production Mode & Process
8.2 Hyperimmune Globulins Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Hyperimmune Globulins Distributors
8.2.3 Hyperimmune Globulins Customers
9 GLOBAL HYPERIMMUNE GLOBULINS ANALYZING MARKET DYNAMICS
9.1 Hyperimmune Globulins Industry Trends
9.2 Hyperimmune Globulins Industry Drivers
9.3 Hyperimmune Globulins Industry Opportunities and Challenges
9.4 Hyperimmune Globulins Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
